论文部分内容阅读
目的探讨特布他林联合布地奈德雾化吸入治疗支气管哮喘的临床效果。方法选取我院72例支气管哮喘患者,随机分为对照组和试验组各36例,均给予止咳、平喘、抗感染等常规治疗,对照组在常规治疗基础上单用布地奈德雾化吸入,试验组应用特布他林+布地奈德雾化吸入,比较两组临床效果。结果试验组临床有效率88.89%,显著高于对照组75.0%(P<0.05);试验组咳嗽、气喘、哮鸣音消失时间均短于对照组(P<0.05);两组在治疗过程中均未出现严重不良反应。结论特布他林+布地奈德雾化吸入治疗支气管哮喘效果显著,安全可靠,值得在临床上大力推广应用。
Objective To investigate the clinical efficacy of terbutaline combined with budesonide inhalation in the treatment of bronchial asthma. Methods 72 cases of bronchial asthma in our hospital were randomly divided into control group and experimental group of 36 cases, were given conventional treatment of cough, asthma, anti-infection, the control group on the basis of routine treatment alone budesonide inhalation , The experimental group using terbutaline + budesonide inhalation, the clinical effects of two groups were compared. Results The clinical effective rate in trial group was 88.89%, which was significantly higher than that in control group (75.0%, P <0.05). The disappearance time of cough, asthma and wheeze in trial group were shorter than that in control group (P <0.05) No serious adverse reactions occurred. Conclusion Terbutaline and budesonide inhalation are effective in treating bronchial asthma, which is safe and reliable. It is worth to be popularized and applied clinically.